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It is estimated that more than 1 million Chinesepeople sustain traumatic brain injury (TBI) annually,nearly 10% of whom are dead and 30% are compli-
cated with physical, cognitive, behavioral and/or psy-
chosocial impairments in China. A lot of experimental
researches and clinical trials of head trauma have been
made in China recently, which improves the understand-
ing of pathological mechanisms and prognosis of se-
vere traumatic brain injury.
Guidelines for treatment of head trauma in China
Since “the Guidelines for the Management of Severe
Traumatic Brain Injury”  (the first, second and third
editions) have been published in USA, more and more
neurosurgeons have applied the guidelines to treat se-
vere traumatic brain injury in China. More than 13 000
neurosurgeons in over 3000 hospitals are qualified to clini-
cally treat head trauma patients in China. Chinese Neu-
rosurgical Association (CNA) started to set up the Chi-
nese guidelines for diagnosis and treatment of head
trauma 10 years ago, and recently published the book
entitled “Chinese Guidelines for Diagnosis and Treatment
of Head Trauma”. CNA is promoting all neurosurgeons
to learn and apply the guidelines to treat head trauma
patients, especially for severe traumatic brain injured
patients in China. The guidelines for management of
severe traumatic brain injury have been widely applied
in Shanghai, Tianjin, Beijing and eastern areas of China.
However, it is certainly essential to promote the appli-
cation of the guidelines in western and middle areas of
China. The experts of CNA are travelling to different ar-
eas of China and giving lectures on how to correctly
apply guidelines to treat the patients with head trauma.
Hopefully, more and more Chinese neurosurgeons will
accept the guidelines in the future in order to improve
the clinical outcome of patients with head trauma in
China.
Mild to moderate hypothermia for treatment of pa-
tients with severe traumatic brain injury in China
Mild to moderate hypothermia as a treatment of brain
injury has been a major concern of research during the
last decade. Laboratory studies have shown that mild
to moderate hypothermia (at 32-35°C) has a significant
protective effect, diminishes the neural damage, reduces
the mortality as well as improves neurological outcome.
Since 1990s, more than 30 clinical trials of mild-to-
moderate hypothermia have been applied to treat over
1 000 patients with severe TBI in USA, Europe, Japan
and China. Most of clinical findings suggest that mild
hypothermia may improve the outcomes of severe trau-
matic brain injured patients with intracranial hyperten-
sion when cooling is maintained for over 48 hours, even
it is not conclusive. Chinese neurosurgeons at Shang-
hai Renji Hospital and Tianjin Huanhu Hospital are the
first group to apply long-term mild hypothermia (>48
hours) for treatment of severe traumatic brain injured
patients in the world. Furthermore, mild hypothermia
significantly decreases ICP values when refractory in-
tracranial hypertension can not be controlled by con-
ventional measures in patients with severe traumatic
brain injury. However, prolonged mild to moderate hy-
pothermia may be associated with high incidence of
pneumonia and hypokalemia which should be prevented.
Some clinical trials have not shown any therapeutic
effect of mild to moderate hypothermia in severe trau-
matic brain injury, which may be related to the delayed
cooling time after trauma, short duration of cooling, and
fast rewarming speed of mild to moderate hypothermia.
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Standard trauma craniectomy for massive cere-
bral contusion and refractory intracranial hyper-
tension
Refractory intracranial hypertension caused by
massive cerebral contusion, intracerebral/subdural
hematoma, and brain edema in patients with severe
traumatic brain injury is still the most important prog-
nostic factor for such patients. However, the optimum
technique for surgical decompression for refractory in-
tracranial hypertension caused by severe head injury
remains a subject of controversy. The American Asso-
ciation of Neurological Surgeons (AANS) considers
decompressive craniectomy as one of several “second-
tier therapies” for refractory intracranial hypertension
resulting from severe TBI. Yet some neurosurgeons have
recently confirmed the usefulness of decompressive
craniectomy, and recommended it as the procedure of
first choice for refractory intracranial hypertension in
severe head injury. This raises the question of whether
standard trauma craniectomy (STC) or limited craniec-
tomy (LC) is the most effective technique for decom-
pressive craniectomy in such cases. Unfortunately, a
review of the literature does not provide a definitive
answer. Nevertheless, in China and other countries, LC
has remained the predominant surgical technique for
treating severely head-injured patients with refractory
intracranial hypertension. Therefore, it is essential to
compare the efficacy of STC and LC for severe trau-
matic brain injury with refractory intracranial hyperten-
sion and massive cerebral contusion. Chinese
neurosurgeons have made a series of clinical trials in-
cluding Shanghai Renji Hospital, Guangzhou Nanfang
Hospital, Tianjin Wujin Hospital, and Zhejiang Zhuji
Hospital. The results indicate that STC can significantly
improve the outcome in severe TBI with refractory intra-
cranial hypertension and massive frontotemporoparietal
contusion with or without intracerebral or subdural
hematoma. More and more Chinese neurosurgeons
would like to use STC to treat surgically severe trau-
matic brain injured patients with massive cerebral con-
tusion and refractory intracranial hypertension.
Neural stem cells transplantation for recovery of
neurological functions in patients with severe trau-
matic brain injury
Neural stem cells (NSCs) provide the potential hope
of neurological recovery for patients with severe trau-
matic brain injury. More and more laboratory data have
confirmed that transplanted NSCs in cerebral paren-
chyma are able to differentiate into neurons and move
to damaged areas, which may establish axonal con-
nection with original neurons for restoring the neuro-
logical function of patients with cerebral damage. Some
neurosurgeons have made clinical trials to explore its
possibility and usefulness. Neurosurgeons at Shang-
hai Huashan hospital have recently performed NSCs
transplantation in more than 20 cases of cerebral con-
tusion and got marked neurological recovery after NSCs
transplantation. However, its clinical trial of NSCs is
discontinued right now. There are still some clinical tri-
als of NSCs to treat patients with coma, paralysis and
other neurological dysfunction following severe traumatic
brain injury or stroke. Definitely, NSCs transplantation
should not be used in clinic because of the following
reasons: first of all, NSCs transplantation has not been
permitted to treat patients by National Health Ministry;
secondly, the differentiation of NSCs into neurons can-
not be controlled well, and most of NSCs differentiate
into gliacytes, which may cause glioma confirmed by
laboratory study; thirdly, there is a shortage of tools
and evidences to confirm morphological and functional
roles of NSCs in human patients. So, more laboratory
studies need to be done. It is a long way to go before
recommendation of clinical application.
Early cranioplasty for cranial defect after decom-
pressive craniectomy in patients with severe trau-
matic brain injury
Traditionally, cranioplasty is performed within 6
months after decompressive craniectomy in patients
with severe traumatic brain injury. Recently, more and
more Chinese neurosurgeons prefer early cranioplasty
(1-3 months) instead of delayed cranioplasty (6 months)
for patients with decompressive craniectomy. Chinese
neurosurgeons at Guangzhou Nanfang Hospital, Shang-
hai Renji Hospital, and Tianjin Wujin Hospital have found
that early cranioplasty may promote the recovery of
consciousness and improve the neurological functions
without any major complications. However, early cranio-
plasty may not be applied for severe traumatic brain in-
jured patients with primary brain stem injury, GCS< 5,
age>65 years or < 12 years, or infection of central ner-
vous system.
Genomics and proteomics of brain tissue follow-
ing traumatic brain injury
In order to explore the early transcriptional changes
of hippocampus after TBI, neurosurgeons at Shanghai
Chinese Journal of Traumatology 2008; 11(4):222-224. 224 .
Renji Hospital have made laboratory study and estab-
lished fluid-percussion (F-P) brain injury model.
Affymetrix rat genome 230 2.0 array was used to de-
tect the gene expression profile of hippocampus in con-
trol group or brain injury group. Laboratory data showed
that 159 transcrips in TBI group changed significantly
(much more than 2 folds) as compared with the control
group. Of those with identified gene ontology function
category, 136 transcrips were up-regulated and 23
transcrips were down-regulated. Preliminary data sug-
gest that early transcriptional changes of hippocampus,
especially a large amount of up-regulated genes, de-
tected after traumatic brain injury in rats may be re-
lated to secondary injuries after TBI. Furthermore,
Neurosurgeons at Shanghai Renji Hospital have explored
the differential protein expression levels of hippocam-
pus in rats by proteomics technique between TBI group
and control group. The total protein mixture extracted
in protein lysate was separated with two dimensional
differential fluorescence in-gel electrophoresis (DIGE).
The differential protein spots were identified by matrix-
assisted laser desorption ionization time of flight mass
spectrometry (MS-TOLF). Laboratory data showed that
17 protein spots were found with statistically signifi-
cant change. Fourteen products of protein spots were
identified by mass spectroscopy and two of them were
repeated. And the actual products of proteins were
thirteen, including cytoskeletons, energy-related
enzymes, nucleic acids synthetic proteins, oxidative
and stress proteins, synapse function related proteins,
intracellular signal transduction proteins, and other un-
known proteins. These differential proteins may be re-
lated to the pathophysiological mechanisms of TBI. To
understand complex protein-protein association and
molecular pathways of post-brain injury may help us
generate potential diagnosis and therapies.
Neurosurgeons in Tianjin General Hospital have
analyzed the difference of gene expression profile be-
tween the traumatic and normal human brain and look
for new molecular biological strategies to prevent and
treat brain trauma. There were 87 common genes in
those differentially expressed genes from traumatic
brains as compared with the normal brain. Sixty genes
were up-regulated and 27 were down-regulated. Among
the up-regulated genes, 44 genes were categorized into
12 functional categories and the other 16 genes’ func-
tion was not be clarified yet. Among the down-regu-
lated genes, 7 genes were categorized into 4 functional
categories and the other 20 genes’ function remained
unknown. Those functional genes were searched in
PubMed. It was found that cd44, cc12, tieg, vegf, cd14,
xbpl, egrl, rgs2,fos, il-lb, timpl, gadd45a, cdkn1a, cnn3
and sppl were once reported in the literature on brain
trauma. And qRT and PCR confirmed the reliability of
the chip data. New molecular biological strategies for
treating brain trauma will be developed and certainly
needs more exploration in the future.
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